📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). (2020)

First Author: Yiu ZZN
Attributed to:  MICA: The Newcastle Proximity Laboratory funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bjd.18981

PubMed Identifier: 32124442

Publication URI: http://europepmc.org/abstract/MED/32124442

Type: Journal Article/Review

Volume: 183

Parent Publication: The British journal of dermatology

Issue: 2

ISSN: 0007-0963